<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2016-05-07</publicationDate>
    
        <volume>9</volume>
        <issue>2</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>9966</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Anti-trypanosomal activity of Carica papaya aqueous seed extracts in mice</title>

    <authors>
	 


      <author>
       <name>Nurul Jamiiah A. Samad</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>B.A.H. Zainal-Abidin</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, UKM, 43600 Bangi, Selangor Malaysia  </affiliationName>
    

		
		<affiliationName affiliationId="2">Faculty of Medicine, Universiti Teknologi, MARA UiTM, 40450  Shah Alam, Selangor.</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">A study was conducted to evaluate the anti-parasitic effects of the aqueous seed extracts of papaya (<em>Carica papaya</em>) on the infections of parasitic <em>Trypanosoma evansi</em> in mice. Groups of male and 6 weeks old ICR mice (n=5) were infected with 5x10<sup>3</sup> parasites intraperitoneally (i.p) on day 0. The positive control group was treated with an anti-protozoal drug berenil (0.35mg/100g body weight, BW) while the negative control group left untreated. The experimental groups were either treated i.p with 250, 500 or 750mg/kg BW fresh aqueous seed extracts of papaya prepared in dH<sub>2</sub>O. The treatments were given 5 days pre-infection, concurrently with the infection on day 0 or 5 days post-infection and continued daily until the mice succumbed or survived. Giemsa-stained thin blood smears were prepared following the infection for monitoring daily parasitaemia and determining prepatent period. The results showed that there was no significant difference in the prepapent period (2-3 days) between the control and experimental groups (p&gt;0.05). However the patterns of parasitaemias of  the control and experimental groups were significantly different (p&lt;0.05). Parasitaemia in negative control group increased drastically until all the mice succumbed within 5 days post-infection while parasitaemia in positive control group was shorted-lived for 3 days and all mice survived. On the other hand, reduction of parasitaemia was observed in all experimental groups which were associated with the regimes of the treatment. The pre-infection and concurrent treatments were more effective than post-infection treatment in reducing parasitaemias and lengthening the survival time of the treated mice. The treatment dose of 750mg/kg BW was found to be the most effective dose.  Results of this study indicated that the aqueous seed extracts of <em>Carica papaya</em>  have  anti-parasitic activity against <em>T. evansi.</em></abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol9no2/anti-trypanosomal-activity-of-carica-papaya-aqueous-seed-extracts-in-mice/</fullTextUrl>



      <keywords language="eng">
        <keyword>Anti-trypanosomal activity; aqueous seed extract; <em>Carica papaya;</em> <em>Trypanosoma evansi</em></keyword>
      </keywords>

      <keywords language="eng">
        <keyword> parasitaemia</keyword>
      </keywords>

  </record>
</records>